Cervantez, Sherri RauenzahnSchool of Medicine |
|
7/2017 - Present | Assistant Professor/Clinical and UT Health Cancer Center Director of Palliative Oncology | UT Health San Antonio MD Anderson Cancer Center, Medicine, San Antonio, TX |
Year | Degree | Discipline | Institution |
2017 | Clinical Fellowship | Hematology and Oncology | UT Health Science Center San Antonio SAN ANTONIO , TX |
2014 | Clinical Fellowship | Hospice and Palliative Medicine | Virginia Commonwealth University Medical College of Virginia Richmond , VA |
2013 | Residency | Internal Medicine | West Virginia University Morgantown , WV |
2011 | Internship | Internal Medicine | West Virginia University Morgantown , WV |
2010 | MD | Medicine | Virginia Commonwealth University Medical College of Virginia Richmond , VA |
2005 | BS | Neuroscience and Behavioral Biology | Emory University Atlanta , GA |
Palliative Medicine- pain and symptom management throughout the cancer care spectrum |
Date | Description | Institution | # Students |
1/2017 - Present | Preceptor for Internal Medicine Residents and Hematology/Oncology Fellows | UT Health San Antonio Cancer Center, San Antonio, TX | |
Thoracic and Head and Neck Oncology Clinic | |||
1/2017 - Present | Preceptor for Hematology/Oncology Fellows | UT Health San Antonio Cancer Center, San Antonio, TX | |
Supportive Cancer Care Clinic |
Abstract |
Rauenzahn S, Cassel B, Del Fabbro E. A retrospective review of urine drug screen findings in an outpatient palliative care clinic. (Abstract S781); 2015 Feb. (Journal of Pain and Symptom Management; vol. 49, no. 2). |
Alesi E, Rauenzahn S, Lyckholm L. Palliating oncologists: A pilot study on primary palliative care development in hematology-oncology trainee outpatient clinics; 2014 Nov. (Journal of Clinical Oncology; vol. 32, no. 31). |
Shah N, Rauenzahn S, Wen S, Craig M, Kanate A, Hamadani M, Cumpston A. Long Term Outcomes of autologous hematopoietic cell transplant following thiotepa-based high dose therapy in patients with non-Hodgkin lymphoma; 2014 Feb. (Biology of Blood and Marrow Transplantation; vol. 20, no. 2). |
Alesi E, Rauenzahn S, Lyckholm L. Palliating oncologists: A pilot study on primary palliative care development in hematology-oncology trainee outpatient clinics. (suppl31; abstr 21); 2014 Jan. (Journal of Clinical Oncology; vol. Sup31, no. Abs21). |
Journal Article |
Cervantez S, Tenner L, Schmidt S, Aduba I, Jones J, Ali N, and S Singh-Carlson. Symptom Burden and Palliative Referral Disparities in an Ambulatory South Texas Cancer Center Frontiers Oncology 2018 Oct;8. |
Rauenzahn S, Sima A, Cassel B, Noreika D, Gomez T, Ryan L, Wolf C, Legakis, L, Del Fabbro E. Urine drug screen findings among ambulatory oncology patients in a supportive care clinic. doi: 10.1007/s00520-017-3575-1. Epub 2017 Jan 25. PMID 28120116 Supportive Care in Cancer 2017 Jun;25(6):1859-1864. |
Rauenzahn S, Schmidt S, Aduba I, Jones J, Ali N, Tenner L. Integrating palliative care services in ambulatory oncology: An application of the Edmonton Symptom Assessment System (ESAS). doi: 10.1200/JOP.2016.019372. Epub 2017 Mar 16. PMID: 28301279 Journal of Oncology Practice 2017 Apr;13(4):e401-e407. |
Shah N, Rauenzahn S, Veltri L, Wen S, Craig M, Hamadani M, Kanate A, Cumpston A. Long Term Outcomes after Thiotepa-based High dose therapy and Autologous hematopoietic cell transplant in Non-Hodgkin lymphomas. PMID: 27892948 Bone Marrow Transplantation 2017 Feb;52(2):321-322. |
Rauenzahn S, Truong Q, Leadmon S, Goff L, Evans K, Zhang J, Cumpston A, Win S, Craig M, Kanate A, Hamadani M. Predictors and impact of 30-day readmissions on patient outcomes and healthcare costs after allogeneic hematopoietic cell transplantation. doi: 10.1016/j.bbmt.2013.12.559. Epub 2013 Dec 18. PMID: 24361913 Biology of Blood and Marrow Transplantation 2014 Mar;20(3):415-420. |
Review Article |
Rauenzahn S, Del Fabbro E. Opioid Management of pain: the impact of the prescription opioid abuse epidemic.doi: 10.1097/SPC.0000000000000065. Review. PMID: 25004173 Current Opinion in Supportive and Palliative Care 2014 Sep;8(3):273-278. |